This Tyler Technologies Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Analysts downgraded STZ, TYL, DK, CRBU and PSX; price targets changed for STZ, TYL, DK and PSX.
Stocks · News reference
This Voya Financial Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
Analysts downgraded Voya, Pacira, Genworth, and more, with price-target changes for several.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Argenx, Caribou Biosciences And Other Big Stocks Moving Lower In Thursday’s Pre-Market Session
U.S. stock futures fell, with Dow futures down 450 points. Argenx sank 8.7% after a Sjögren’s trial was halted for futility; others also slid.
HC Wainwright & Co. Downgrades Caribou Biosciences to Neutral
HC Wainwright & Co. analyst Robert Burns downgrades Caribou Biosciences (NASDAQ:CRBU) from Buy to Neutral.
Genworth Financial Q2 2026 Earnings Call: Complete Transcript
Genworth Financial (NYSE:GNW) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts and
Keefe, Bruyette & Woods Downgrades Genworth Financial to Market Perform, Lowers Price Target to $10.5
Keefe, Bruyette & Woods analyst Ryan Krueger downgrades Genworth Financial (NYSE:GNW) from Outperform to Market Perform and lowers the price target from $11.5 to $10.5.
Keefe, Bruyette & Woods Maintains Outperform on Genworth Financial, Lowers Price Target to $11.5
Keefe, Bruyette & Woods analyst Ryan Krueger maintains Genworth Financial (NYSE:GNW) with a Outperform and lowers the price target from $12 to $11.5.